Abstract

The growing incidence and prevalence of civilization diseases is prompting national and transnational entities to seek instruments that would reverse epidemiological trends. Not without significance is the need to design such solutions that are going to provide an improved relation between the costs incurred to maintain health or recovery and the profit for citizens of continuing to function in good health. In its strategic documents, the European Union indicates the most important development goals in each financial perspective and the tools necessary to achieve them. In the Europe 2020 strategy, a cohesion policy was indicated as an important tool for the implementation of development goals, focusing on supporting activities leading to the equalisation of economic and social conditions in all regions of EU countries. The implementation of one of the three basic priorities of the Europe 2020 strategy, which is inclusive growth—supporting an economy with a high level of employment and ensuring social and territorial cohesion—assumes, among others, that in 2020, the population at risk of poverty and social exclusion will decrease by 20 million and that the employment rate in the EU will increase to 75%. Meeting the objectives will not be possible without a holistic coordinated approach to healthcare at the national and regional level in accordance with the principle of “health in all policies”. It also requires the involvement of various sources of financing, including structural funds. The EU’s prioritisation of the problems related to ensuring decent conditions for achieving health resulted in the mobilisation of structural funds for actions taken in the healthcare sector. Of particular importance are those actions which are taken to prevent, alleviate, and prevent oncological diseases. An additional contribution to undertaking actions aimed at preventing oncological diseases are the high and often neglected social costs incurred by societies. The goal of the article was to identify and evaluate actions taken in this area in Poland. It was achieved by analysing the literature on the subject and statistical data, and conducting induction based on the above-mentioned sources.

Highlights

  • Over the centuries, global morbidity and mortality have gradually changed the direction and thinking of policy makers shaping healthcare policies

  • These are the PL07 program, “Improving and better adapting healthcare to demographic and epidemiological trends”, including five projects covering: Research, campaigns to promote a healthy lifestyle, retrofitting and modernising medical entities; as well as the PL13 program, “Reducing social inequities in health”, including 26 projects, of which seven are on cancer prevention. All these activities are intended to strengthen the resources of Polish healthcare in order to improve diagnostics, treatment, and access to services, and, reduce the social costs of oncological diseases

  • There are efforts being carried out in parallel in the medical field, where the most effective methods of therapy and drug programs are sought, and in the management field, for which the health policy of the state is of fundamental importance

Read more

Summary

Introduction

Global morbidity and mortality have gradually changed the direction and thinking of policy makers shaping healthcare policies. The analysis of changes in the burden of disease in Poland in 1990–2017, compared to other Central European countries, is part of the previously presented trends [9] These dynamic trends of morbidity and deaths directly point to the emergence of huge losses both in terms of population size and lost productivity understood as a limitation of the possibility of performing work due to health damage. This last statement means that it is necessary to strive to limit these losses by increasing clinical effectiveness in the ongoing treatment process and by minimising non-medical costs arising during the disease. Perfect methods of estimating costs incurred by sick people are used to limit the losses

The Problem of Social Cost Definition and Identification
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.